Bdrelin 11.25mg injection
Trade Name: Bdrelin
Manufacturer: BDR Pharmaceuticals Internationals Pvt Ltd
Presentation: injection
Strength: 11.25mg
Bdrelin 11.25mg injection is a specialty pharmaceutical product offered by Rizochem Pharmaceuticals wholesaler and exporter. This Bdrelin 11.25mg injection contains leuprorelin acetate, a synthetic hormone used in the treatment of hormone-sensitive cancers such as prostate cancer in men, as well as conditions such as endometriosis and uterine fibroids in women.
Key Features:
Composition: Each injection contains 11.25 mg of leuprorelin acetate.
Indications: Primarily prescribed for the management of advanced prostate cancer, endometriosis, and fibroids.
Mechanism of Action: Leuprorelin works by reducing the levels of certain hormones in the body, which helps slow the growth of hormone-sensitive tumors.
Administration: Bedralein is administered as a long-acting injection, usually once every three months, making it convenient for long-term treatment.
Packaging: Bdrelin 11.25mg injection is carefully packaged to maintain its efficacy and is available for worldwide distribution.
Check this immunosuppressant product Immutil 500mg Tablet
We are an exporter from India and work in excess countries like the UAE, Oman, Qatar, Myanmar, Saudi Arabia, Netherlands, Albania, Saint Lucia, Jordan, Romania, South Africa, etc.